In a groundbreaking advancement poised to redefine industrial vitamin production, researchers have unveiled a novel metabolic engineering strategy to boost riboflavin (vitamin B2) synthesis in the bacterium Bacillus subtilis. Riboflavin holds essential biological significance as the precursor to ubiquitous cellular cofactors flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD), which are integral to numerous redox reactions across cellular metabolism. The latest study provides a nuanced understanding of purine metabolism regulation and harnesses transporter proteins to alleviate metabolic bottlenecks, culminating in significantly enhanced riboflavin yields.
Bacillus subtilis has long been a favored microbial chassis for riboflavin production due to its robustness, rapid growth kinetics, and well-established genetic tools. Despite high intrinsic productivity, riboflavin biosynthesis remains tightly constrained by the intracellular supply of guanosine triphosphate (GTP), a critical precursor derived from the purine biosynthesis pathway. This pathway is intricately controlled by multifaceted regulatory circuits including the PurR repressor, guanine-responsive riboswitches located in the 5’-untranslated region of the pur operon, and end-product feedback inhibition by purine nucleotides. Such regulation ensures cellular homeostasis but imposes intrinsic limits on precursor availability, throttling riboflavin biosynthetic flux.
In this study, the investigative team meticulously dissected purine transport mechanisms to exploit them as levers for pathway deregulation. They identified two pivotal transporters, NupG and PbuO, that modulate guanine flux across the bacterial membrane. Functional assays involving resting cell transformations and fermentations revealed that NupG functions primarily as a guanine efflux pump, reducing intracellular guanine concentrations, whereas PbuO facilitates guanine import. By genetically engineering B. subtilis to overexpress nupG, the researchers successfully decreased intracellular guanine levels by nearly half compared to the wild-type parent strain.
This reduction in guanine concentrations effectively diminished the repression exerted by the guanine-responsive riboswitch upstream of the pur operon. The consequent de-repression led to upregulated expression of the entire operon, significantly enhancing the metabolic throughput of the de novo purine synthesis cascade. As the purine pathway was relieved from riboswitch-mediated constraints, intracellular GTP pools expanded, directly augmenting the substrate supply required for efficient riboflavin biosynthesis.
The engineered B. subtilis strain, designated BR-02, manifested a remarkable 15.3% increase in riboflavin titer, reaching 1,508.22 mg/L. Notably, these metabolic modifications preserved cellular energy charge and did not adversely affect growth rates or glucose consumption, reinforcing the strategy’s metabolic robustness. Maintaining energy homeostasis is critical in microbial cell factories to prevent trade-offs that compromise productivity or lead to undesirable physiological stresses.
Beyond empirical performance improvements, the study’s significance lies in its conceptual framework. By introducing transporter-mediated regulation of intracellular metabolite pools, the research establishes a modular approach to mitigate feedback inhibition in biosynthetic pathways. Such an approach transcends conventional gene overexpression or knockouts, introducing a dynamic control layer that fine-tunes metabolite concentrations through membrane transport manipulations. This engineering paradigm could be extrapolated to other microbial platforms and biosynthetic targets subject to stringent regulatory constraints.
Crucially, the mechanistic insights into purine transporter functions and riboswitch regulation enrich fundamental understanding of microbial metabolic networks. Riboswitches are RNA elements that respond to metabolite ligands to regulate gene expression post-transcriptionally, representing elegant cellular sensors. Manipulating their cognate ligand availability through transporter activity heralds a novel strategy for precise gene expression control in metabolic engineering.
The research team employed sophisticated metabolic and molecular biology techniques to validate transporter functions and monitor intracellular metabolite dynamics. Resting cell transformation assays provided controlled environments to quantify guanine flux, while fermentation studies integrated systems-level physiological assessments. Such integrative methodologies underscore the importance of combining genetic modifications with comprehensive phenotypic characterizations to achieve sustainable and scalable bioproduction improvements.
This work not only advances the production efficiency of an industrially vital vitamin but also exemplifies how deep mechanistic insights can inspire rigorously engineered biotechnological solutions. As riboflavin continues to be a critical nutrient for human and animal health, improvements in its microbial biosynthesis contribute to more sustainable and cost-effective production routes, minimizing dependency on chemical synthesis or extraction from natural sources.
Future directions for this line of investigation may include exploring transporter engineering in tandem with synthetic riboswitch design, enabling even more nuanced metabolic regulation. Furthermore, coupling guanine transporter modulation with systems biology modeling and metabolic flux analysis might reveal additional intervention points to maximize precursor supply and product output. Integrating these strategies will further transform microbial strains into efficient cell factories tailored for diverse biomanufacturing applications.
In summary, this pioneering study elucidates a transformative approach to enhanced riboflavin production in Bacillus subtilis by leveraging guanine transporters to modulate purine biosynthesis regulation. By alleviating riboswitch-mediated repression through intracellular guanine depletion, it unlocks new vistas for metabolic pathway engineering. The findings mark a significant leap toward precise, finely-tuned microbial manufacturing platforms capable of meeting growing demands for vitamins, nutraceuticals, and other bioactive compounds.
Subject of Research: Not applicable
Article Title: Enhancing riboflavin production in Bacillus subtilis via guanine transporter-mediated regulation of the purine biosynthesis pathway
News Publication Date: 30-Mar-2026
Web References: http://dx.doi.org/10.1007/s43393-026-00452-w
Image Credits: HIGHER EDUCATION PRESS
Keywords: Bacillus subtilis, riboflavin, vitamin B2, purine biosynthesis, guanine transporter, metabolic engineering, riboswitch, de novo synthesis, microbial fermentation, NupG, PbuO, feedback inhibition
